Poxel S.A. (OTCMKTS:PXXLF) Short Interest Down 98.9% in February

Poxel S.A. (OTCMKTS:PXXLF) was the target of a large drop in short interest in the month of February. As of February 28th, there was short interest totalling 100 shares, a drop of 98.9% from the February 13th total of 9,400 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days. Currently, 0.0% of the company’s shares are sold short.

Poxel Stock Performance

PXXLF remained flat at $0.25 during trading on Wednesday. The business has a 50 day moving average price of $0.25 and a 200 day moving average price of $0.46. Poxel has a 12-month low of $0.25 and a 12-month high of $0.25.

About Poxel

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.